Cost of severe asthma in Brazil-systematic review
- PMID: 27116649
- DOI: 10.3109/02770903.2016.1171338
Cost of severe asthma in Brazil-systematic review
Abstract
Introduction: Severe asthma is characterized by frequent exacerbations, symptoms limiting daily activities and nocturnal symptoms. It requires the continuous use of medications, at high doses, and, sometimes, continuous use of oral corticosteroids, representing a significant burden to health system and society. This systematic review sought to address economic data related to severe asthma in Brazil.
Method: In June 2014, electronic searches were conducted to identify relevant publications. Quality criteria were developed and applied to each selected study. In order to compare results across the selected studies, costs were refined to an annual basis, grouped according to the study perspective, inflated and converted to 2014 USD.
Results: Cost analyses from the Brazilian public health system perspective were derived from two studies and showed an average annual hospital cost per patient of 135 USD and 733 USD, respectively. From the family perspective, average annual direct costs per patient varied from 764 USD to 929 USD.
Conclusion: Hospitalizations and medications seem to be the most important resources funded by the Brazilian public health system and by patients and their families. Although further studies are necessary, as information on cost of this disease is scarce in Brazil, these findings suggest that there is a potential room for improving severe asthma care among Brazilian patients.
Keywords: Cost of illness; asthma; burden of illness; health care costs; review.
Similar articles
-
Economic impact of severe asthma in Spain: multicentre observational longitudinal study.J Asthma. 2019 Aug;56(8):861-871. doi: 10.1080/02770903.2018.1499035. Epub 2018 Oct 9. J Asthma. 2019. PMID: 30003827
-
Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective.Eur Ann Allergy Clin Immunol. 2021 May;53(3):128-137. doi: 10.23822/EurAnnACI.1764-1489.149. Epub 2020 May 6. Eur Ann Allergy Clin Immunol. 2021. PMID: 32372589
-
Cost, morbidity, and control of asthma in Hungary: The Hunair Study.J Asthma. 2003 Sep;40(6):673-81. doi: 10.1081/jas-120021100. J Asthma. 2003. PMID: 14579999
-
Cost-effectiveness of asthma therapy: a comprehensive review.J Asthma. 2015;52(6):529-37. doi: 10.3109/02770903.2014.999283. Epub 2015 Jul 25. J Asthma. 2015. PMID: 25539023 Review.
-
Economic burden of asthma: a systematic review.BMC Pulm Med. 2009 May 19;9:24. doi: 10.1186/1471-2466-9-24. BMC Pulm Med. 2009. PMID: 19454036 Free PMC article. Review.
Cited by
-
Severe asthma phenotyping: does the definition of different phenotypes matter?J Bras Pneumol. 2022 Jul 8;48(3):e20220176. doi: 10.36416/1806-3756/e20220176. J Bras Pneumol. 2022. PMID: 35830055 Free PMC article. No abstract available.
-
Temporal evolution of and factors associated with asthma and wheezing in schoolchildren in Brazil.J Bras Pneumol. 2019 Jun 27;45(3):e20180138. doi: 10.1590/1806-3713/e20180138. J Bras Pneumol. 2019. PMID: 31271601 Free PMC article.
-
2021 Brazilian Thoracic Association recommendations for the management of severe asthma.J Bras Pneumol. 2021 Dec 15;47(6):e20210273. doi: 10.36416/1806-3756/e20210273. eCollection 2021. J Bras Pneumol. 2021. PMID: 34932721 Free PMC article. Review.
-
The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system.J Bras Pneumol. 2017 May-Jun;43(3):163-168. doi: 10.1590/S1806-37562016000000352. J Bras Pneumol. 2017. PMID: 28746526 Free PMC article.
-
An expert review on breaking barriers in severe asthma in Brazil: Time to act.Chron Respir Dis. 2021 Jan-Dec;18:14799731211028259. doi: 10.1177/14799731211028259. Chron Respir Dis. 2021. PMID: 34167379 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical